Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors
- 1 April 2001
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 29 (4) , 416-424
- https://doi.org/10.1016/s0301-472x(01)00611-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Circular Permutation of Granulocyte Colony-Stimulating FactorBiochemistry, 1999
- Circular Permutation of the Granulocyte Colony-Stimulating Factor Receptor Agonist Domain of MyelopoietinBiochemistry, 1999
- Identification of a Cys Motif in the Common β Chain of the Interleukin 3, Granulocyte-Macrophage Colony-stimulating Factor, and Interleukin 5 Receptors Essential for Disulfide-linked Receptor Heterodimerization and Activation of All Three ReceptorsPublished by Elsevier ,1998
- Critical proline residues of the cytoplasmic domain of the IL-5 receptor α chain and its function in IL-5-mediated activation of JAK kinase and STAT5International Immunology, 1996
- Dimerization of the Extracellular Domain of Granulocyte-Colony Stimulating Factor Receptor by Ligand Binding: A Monovalent Ligand Induces 2:2 ComplexesBiochemistry, 1996
- Saturation Mutagenesis of Human Interleukin-3Published by Elsevier ,1995
- Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3.Proceedings of the National Academy of Sciences, 1995
- Haemopoietic receptors and helical cytokinesImmunology Today, 1990
- Stimulation of human hematopoietic colony formation by recombinant gibbon multi-colony-stimulating factor or interleukin 3.Journal of Clinical Investigation, 1987
- Measurement of specific radioactivities in labelled hormones by self-displacement analysisBiochemical Journal, 1983